Source - RNS
RNS Number : 1966H
Quantum Pharma PLC
06 June 2017

For immediate release

6 June 2017


Quantum Pharma Plc

('Quantum' or the 'Company')


Annual Report and Accounts

Notice of Annual General Meeting


Quantum Pharma Plc (AIM: QP.), the service-led niche pharmaceutical developer, manufacturer and supplier, announces that in accordance with AIM Rule 20, electronic copies of its Annual Report and Accounts for the year ended 31 January 2017 together with the Notice of Annual General Meeting and Form of Proxy are available from the Company's investor relations website at .  Hard copies of the 2017 Annual Report and Accounts, Notice of Annual General Meeting and Form of Proxy were posted to shareholders yesterday.


The Company's Annual General Meeting will be held at 1:00 p.m. on Thursday, 6 July 2017 at the offices of Muckle LLP, Time Central, 32 Gallowgate, Newcastle upon Tyne, NE1 4BF.


- Ends -


For further information:

Quantum Pharma Plc


Chris Rigg, Chief Executive Officer

Tel: +44 (0) 1207 279 404

Gerard Murray, Chief Financial Officer

[email protected]



N+1 Singer


(Nominated Advisor & Broker)


Sandy Fraser / Nick Owen / James White

Tel: +44 (0) 20 7496 3000


Media enquiries:



Henry Harrison-Topham / Sophie Cowles

Tel: +44 (0) 20 7466 5000

[email protected]


Notes to Editors

Quantum Pharma Plc is a service-led, niche pharmaceutical developer, manufacturer and supplier to the retail pharmacy, pharmaceutical wholesale, hospital and homecare markets. Quantum Pharma Plc operates through three divisions - Specials, Niche Pharmaceuticals and Medication Adherence - offering a portfolio of innovative and complementary products and services.


For further information, please visit  

This information is provided by RNS
The company news service from the London Stock Exchange